GSK completes acquisition of Boston-based, clinical-stage biopharma company, IDRx, Inc.

The FTSE 250 business's stock jumped 4.7%, or 6.3p, to 141.8p as investors bet it could be next food delivery group to be ...

GSK plc has completed its previously announced acquisition of IDRx Inc., a Boston-based, clinical-stage biopharmaceutical ...

GSK (GSK) plc announced that it has completed the acquisition of IDRx, Inc., a Boston-based, clinical-stage biopharmaceutical company dedicated ...

Two former FTSE 100 stocks were in the spotlight today after Just Eat Takeaway.com backed a £3.4 billion takeover and B&M ...

GSK plc (LSE/NYSE: GSK) today announced that it has completed the acquisition of IDRx, Inc. (IDRx), a Boston-based, ...

It forecasts that the repurchases - which are due to complete in 18 months - will boost core earnings by 6% to 8% in 2025 ...

GSK on Monday also said it has start the GBP2 billion buyback programme that it announced earlier this month, starting with an initial GBP700 million tranche.

In corporate news, Prosus has agreed to acquire Just Eat Takeaway.com for around EUR4.1 billion. Here is what you need to know at the London market open: FTSE 100: called down 3.1 points at 8,656.27 ...

GSK’s share price has fallen a long way on a combination of factors, but do its recent strong results leave its current price looking cheap to me?